Published in Ann Intern Med on August 01, 1987
Early enteral feeding, compared with parenteral, reduces postoperative septic complications. The results of a meta-analysis. Ann Surg (1992) 4.26
A meta-analysis of selective versus routine nasogastric decompression after elective laparotomy. Ann Surg (1995) 2.58
Postoperative feeding. BMJ (1991) 1.82
A double-blind, randomized clinical trial comparing soybean oil-based versus olive oil-based lipid emulsions in adult medical-surgical intensive care unit patients requiring parenteral nutrition. Crit Care Med (2012) 1.58
Elemental diet and IV-TPN-induced bacterial translocation is associated with loss of intestinal mucosal barrier function against bacteria. Ann Surg (1995) 1.39
The effect of postoperative intravenous feeding (TPN) on outcome following major surgery evaluated in a randomized study. Ann Surg (1993) 1.26
Pretreatment malnutrition and quality of life - association with prolonged length of hospital stay among patients with gynecological cancer: a cohort study. BMC Cancer (2010) 0.95
Substitution of standard soybean oil with olive oil-based lipid emulsion in parenteral nutrition: comparison of vascular, metabolic, and inflammatory effects. J Clin Endocrinol Metab (2011) 0.91
Enteral and parenteral nutrition in the perioperative period: state of the art. Nutrients (2013) 0.90
Debate: Albumin administration should not be avoided. Crit Care (2000) 0.88
Parenteral nutrition use at a university hospital. Factors associated with inappropriate use. West J Med (1990) 0.87
Management of hyperglycemia during enteral and parenteral nutrition therapy. Curr Diab Rep (2013) 0.81
The role of the enteral route and the composition of feeds in the nutritional support of malnourished surgical patients. Nutrients (2012) 0.80
Medical nutrition therapy in hospitalized patients with diabetes. Curr Diab Rep (2012) 0.78
Is there a role for parenteral feeding in clinical medicine? West J Med (1996) 0.75
Effects of preoperative nutritional support on colonic anastomotic healing in malnourished rats. Ulus Cerrahi Derg (2015) 0.75
On enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg (1995) 0.75
Enterocutaneous fistula and small bowel evisceration of twenty-five years' duration: successful surgical and nutritional management. Dig Dis Sci (2007) 0.75
FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex. Cell (1996) 12.07
Conflict of interest in the debate over calcium-channel antagonists. N Engl J Med (1998) 11.14
How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ (1992) 10.40
FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell (1995) 9.81
Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell (1995) 9.22
The receptor for the cytotoxic ligand TRAIL. Science (1997) 6.39
Screening for prostate cancer. A decision analytic view. JAMA (1994) 5.83
Meta-analysis in clinical research. Ann Intern Med (1987) 5.16
Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol (1992) 4.86
Breast cancer survival by teaching status of the initial treating hospital. CMAJ (2001) 4.75
Shopping around for hospital services: a comparison of the United States and Canada. JAMA (1998) 4.41
What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr (1987) 4.21
Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol Cell (2000) 4.19
Molecular ordering of the cell death pathway. Bcl-2 and Bcl-xL function upstream of the CED-3-like apoptotic proteases. J Biol Chem (1996) 3.97
On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions. Biostatistics (2001) 3.83
FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem (1996) 3.72
Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med (1993) 3.53
Interaction of CED-4 with CED-3 and CED-9: a molecular framework for cell death. Science (1997) 3.51
Screening for colon cancer--can we afford colonoscopy? N Engl J Med (2001) 3.48
The validity of a sore throat score in family practice. CMAJ (2000) 3.34
A novel RING finger protein interacts with the cytoplasmic domain of CD40. J Biol Chem (1994) 3.13
Direct and indirect costs of asthma in Canada, 1990. CMAJ (1996) 3.07
Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy. A meta-analysis. Gastroenterology (1989) 2.88
Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science (1996) 2.87
Role of CED-4 in the activation of CED-3. Nature (1997) 2.76
Nutritional assessment: a comparison of clinical judgement and objective measurements. N Engl J Med (1982) 2.74
Variation in breast cancer surgery in Ontario. CMAJ (1994) 2.70
Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis (1999) 2.69
Comparison of an aggressive (U.S.) and a less aggressive (Canadian) policy for cholesterol screening and treatment. Ann Intern Med (1991) 2.61
Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA (2001) 2.49
Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol (2001) 2.41
Tumor necrosis factor-alpha induction of novel gene products in human endothelial cells including a macrophage-specific chemotaxin. J Biol Chem (1990) 2.37
Thoracic human vertebrae. Quantitative three-dimensional anatomy. Spine (Phila Pa 1976) (1991) 2.34
Cervical human vertebrae. Quantitative three-dimensional anatomy of the middle and lower regions. Spine (Phila Pa 1976) (1991) 2.30
Caspase-9, Bcl-XL, and Apaf-1 form a ternary complex. J Biol Chem (1998) 2.25
The privacy paradox: laying Orwell's ghost to rest. CMAJ (2001) 2.22
Randomized, controlled trial of an interactive videodisc decision aid for patients with ischemic heart disease. J Gen Intern Med (2000) 2.21
Asymptomatic primary biliary cirrhosis: a study of its natural history and prognosis. Am J Gastroenterol (1999) 2.19
Nonionic contrast media: economic analysis and health policy development. CMAJ (1989) 2.13
Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med (1986) 2.13
An introduction to multilevel regression models. Can J Public Health (2001) 2.11
When was a "negative" clinical trial big enough? How many patients you needed depends on what you found. Arch Intern Med (1985) 2.11
A randomized crossover trial of Quick Medical Reference (QMR) as a teaching tool for medical interns. J Gen Intern Med (1994) 2.10
Effect of population-based interventions on laboratory utilization: a time-series analysis. JAMA (1998) 2.09
A role for FADD in T cell activation and development. Immunity (1998) 2.09
Cardiac assessment for patients undergoing noncardiac surgery. A multifactorial clinical risk index. Arch Intern Med (1986) 2.08
Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. Arch Intern Med (1995) 2.07
Cost and health implications of cholesterol lowering. Circulation (1992) 2.00
Human lumbar vertebrae. Quantitative three-dimensional anatomy. Spine (Phila Pa 1976) (1992) 1.92
Proteolytic activation of the cell death protease Yama/CPP32 by granzyme B. Proc Natl Acad Sci U S A (1996) 1.90
Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology (1995) 1.90
Paratyphoid fever in India: An emerging problem. Emerg Infect Dis (1999) 1.89
Primer on medical decision analysis: Part 3--Estimating probabilities and utilities. Med Decis Making (1997) 1.84
Decision aids: are they worth it? A systematic review. J Health Serv Res Policy (2001) 1.78
Prognosis, survival, and the expenditure of hospital resources for patients in an intensive-care unit. N Engl J Med (1981) 1.72
Articular facets of the human spine. Quantitative three-dimensional anatomy. Spine (Phila Pa 1976) (1993) 1.69
Age distribution of Helicobacter pylori seroprevalence among young children in a United States/Mexico border community: evidence for transitory infection. Am J Epidemiol (1999) 1.68
Reconsidering sore throats. Part 2: Alternative approach and practical office tool. Can Fam Physician (1997) 1.66
Direct costs of coronary artery bypass grafting in patients aged 65 years or more and those under age 65. CMAJ (1999) 1.61
Reconsidering sore throats. Part I: Problems with current clinical practice. Can Fam Physician (1997) 1.58
Molecular ordering of apoptotic mammalian CED-3/ICE-like proteases. J Biol Chem (1996) 1.57
Primer on medical decision analysis: Part 4--Analyzing the model and interpreting the results. Med Decis Making (1997) 1.57
Efficacy and cost effectiveness of current therapies in Guillain Barre syndrome. J Assoc Physicians India (2001) 1.57
An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial. Gastroenterology (2001) 1.57
Classification systems of soft tissue disorders of the neck and upper limb: do they satisfy methodological guidelines? J Clin Epidemiol (1996) 1.56
Perioperative assessment and management of risk from coronary artery disease. Ann Intern Med (1997) 1.53
Tentative guidelines for using clinical and economic evaluations revisited. CMAJ (1993) 1.53
Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces. CMAJ (2001) 1.52
A Critical Look at HIV-Antibody Tests: 2. Benefits, Risks and Clinical Use. Can Fam Physician (1987) 1.52
Can the standard gamble be used to determine utilities for uncertain health states? An example using postoperative maintenance therapy in Crohn's disease. Med Decis Making (2000) 1.51
Meaning and measurement: an inclusive model of evidence in health care. J Eval Clin Pract (2001) 1.50
The relation of conjunctival pallor to the presence of anemia. J Gen Intern Med (1997) 1.50
Cost comparison of molecular versus conventional screening of relatives at risk for retinoblastoma. Am J Hum Genet (1996) 1.49
Clinical and population epidemiology: beyond sibling rivalry? J Clin Epidemiol (1990) 1.49
Visits by adults to family physicians for the common cold. J Fam Pract (1998) 1.46
Evaluating the accuracy of nutritional assessment techniques applied to hospitalized patients: methodology and comparisons. JPEN J Parenter Enteral Nutr (1984) 1.46
Cost induced by hip fractures. Ir Med J (2008) 1.46
Azathioprine therapy in chronic ulcerative colitis. J Clin Gastroenterol (1990) 1.46
Preoperative fasting for preventing perioperative complications in children. Cochrane Database Syst Rev (2005) 1.45
Autoimmune encephalopathy presenting as a 'posterior circulation stroke'. J Neurol (2010) 1.45
OAS1: a multiple sclerosis susceptibility gene that influences disease severity. Neurology (2010) 1.45
Identification of an epitope in the C terminus of normal prion protein whose expression is modulated by binding events in the N terminus. J Mol Biol (2000) 1.44
Prophylactic oophorectomy in Ontario. Fam Cancer (2001) 1.41
Should ERCP be routine after an episode of "idiopathic" pancreatitis? A cost-utility analysis. Gastrointest Endosc (1996) 1.41
Improving prevention in primary care: evaluating the effectiveness of outreach facilitation. Fam Pract (2008) 1.40
Stress, social support, and emotional distress in a community sample of pregnant women. J Psychosom Obstet Gynaecol (2005) 1.40